Glow 70mg

$99.00

Multi-Peptide Research Blend | Cellular and Extracellular Matrix Research

GLOW 70mg is a multi-peptide research blend combining GHK-Cu, BPC-157, and TB-500 in a single preparation. Commonly listed formulations contain 50mg GHK-Cu, 10mg BPC-157, and 10mg TB-500, totaling 70mg.

Each component has a distinct molecular structure and has been investigated in different areas of preclinical research. The blend brings these components together for laboratory evaluation of their individual characteristics and potential interactions within a combined preparation.

SKU GKOW70 Category

Description

PRODUCT OVERVIEW

Three Peptide Components in One Research Blend

GLOW combines three research compounds:

· GHK-Cu (50mg): A copper-binding tripeptide investigated in research involving extracellular matrix biology, cellular signaling, and peptide-metal interactions.

· BPC-157 (10mg): A synthetic peptide examined primarily in preclinical studies involving cellular and tissue-related biological processes.

· TB-500 (10mg): A research peptide name associated with thymosin beta-4-related research. The exact molecular identity should be verified against the supplier’s specifications.

Together, these components provide a multi-compound preparation for laboratory characterization and comparative research. Evidence involving the individual ingredients does not establish the effectiveness or biological properties of the combined blend.

PRODUCT SPECIFICATIONS

Specification Details
Product Name GLOW 70mg
Compound Classification Multi-peptide research blend
GHK-Cu 50mg
BPC-157 10mg
TB-500 10mg
Total Labeled Quantity 70mg
Price $99.00
Purity Refer to applicable product and lot documentation
Batch Identification Where provided
Supporting Documentation Applicable product or lot documentation

Confirm the blend composition and component identities against the supplier’s current product specifications and applicable COA before publication.

SCIENTIFIC BACKGROUND

GLOW is a blend name rather than a single molecular compound. Its scientific characteristics depend on the identity, composition, and quality of each included peptide.

GHK-Cu has been studied for its copper-binding properties and its relationship with extracellular matrix processes. BPC-157 has primarily been investigated in preclinical experimental models, while thymosin beta-4-related research has examined cellular processes such as cell migration and actin regulation.

These research areas concern different molecular systems. Evidence for an individual ingredient should not be interpreted as proof that the three-component blend produces a particular biological outcome. Research specifically establishing the properties of this exact combined formulation remains limited.

RESEARCH APPLICATIONS

GLOW 70mg may be examined in controlled laboratory settings for:

· Multi-Component Characterization: Evaluation of the reported identity and analytical properties of the individual blend components.

· Peptide-Metal Research: Investigation of the copper-binding characteristics associated with GHK-Cu.

· Cellular Process Research: Review of experimental findings involving cellular signaling and extracellular matrix biology.

· Comparative Analysis: Examination of individual peptide materials alongside a combined preparation.

· Composition Assessment: Evaluation of the stated component quantities and total labeled content.

· Analytical Documentation: Review of batch identifiers, reported purity, and available laboratory findings.

These are potential research areas, not claims of established clinical benefits or demonstrated effects of the combined product.

QUALITY & LABORATORY DOCUMENTATION

Products are supported by applicable third-party laboratory testing documentation. Independent verification and additional testing may be conducted where appropriate.

Researchers should review the available documentation for compound identity, reported purity, analytical methods, laboratory information, and batch identification, where provided. For a multi-component blend, the documentation should identify the relevant components and correspond to the product lot being evaluated.

LOT & BATCH REFERENCE

Where a lot number or batch identifier is provided, retain it alongside the corresponding laboratory documentation. This supports traceability and helps researchers associate analytical results with the relevant blend.

STORAGE & HANDLING

Store and handle GLOW 70mg according to the supplier-provided specifications and applicable laboratory procedures. Refer to the product-specific documentation for storage conditions, packaging requirements, and handling precautions.

RESEARCH USE STATEMENT

GLOW 70mg is offered strictly for laboratory and scientific research purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or prevention of any disease.

IMPORTANT NOTICE

GLOW is a multi-component research blend, and its name alone does not verify composition, purity, or biological activity. Review the applicable product specifications and batch documentation before research use. No claim is made that this product is approved for human use or has established clinical benefits.

Reviews

There are no reviews yet.

Be the first to review “Glow 70mg”

Your email address will not be published. Required fields are marked *